Medication info
Pitavastatin Calcium 2 mg Tablets

Pitavastatin Calcium 2 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium›2mg / 1 tablet
Manufacturer / importer
Hwanin Pharmaceutical Co., Ltd.
Appearance
White, round film-coated tablets with a line.
Packaging
For domestic use) 100 tablets (10 tablets/PTP × 10), 300 tablets/bottle, for export) 30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201103425 · Approved 2011.05.24 · Insurance code 657202320

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is inadequate, the dose may be increased to a maximum of 4 mg daily. Depending on the LDL cholesterol level, treatment goal, and patient response, the dose should be appropriately adjusted at intervals of 4 weeks or longer. The therapeutic effect of this drug is maintained with continued administration.

Ingredients

Manufacturer
Hwanin Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • LDL cholesterol
  • apo-B protein
  • and triglyceride levels.
View approved original text

This medication helps to lower total cholesterol, LDL cholesterol, apo-B protein, and triglyceride levels and increase HDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It is used to improve health risks associated with these lipid abnormalities.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is inadequate, the dose may be increased to a maximum of 4 mg daily. Depending on the LDL cholesterol level, treatment goal, and patient response, the dose should be appropriately adjusted at intervals of 4 weeks or longer. The therapeutic effect of this drug is maintained with continued administration.

Precautions

This medication should not be used in certain patients. First, those who have had an allergy to any of its ingredients should not take it. Patients with active liver disease or ongoing liver dysfunction, and those with severe liver impairment or bile duct obstruction should also avoid its use. Additionally, patients taking cyclosporine, those with myopathy, pregnant or possibly pregnant women, breastfeeding women, and children should not be administered this medication. Since this medication contains lactose, it should also not be given to patients with lactose intolerance or related hereditary disorders. Patients with kidney dysfunction or a history of liver disorders, those who consume alcohol excessively, elderly patients, patients with hypothyroidism, and those with genetic muscle diseases or a history of muscle-related conditions should use this medication with caution. Caution is especially needed when used in conjunction with fibrates or niacin, as this may increase the risk of muscle damage. During treatment, adverse reactions such as muscle pain, weakness, abdominal pain, rash, and itching may occur, and there may be increases in liver function tests or blood abnormalities like thrombocytopenia. If rhabdomyolysis related to muscle damage occurs, medication should be stopped immediately, as it may be accompanied by severe renal impairment. Prior to administration, it is advisable to confirm hypercholesterolemia and to carry out dietary and exercise therapies first. Regular monitoring of blood lipids and liver function tests should be conducted during treatment, and if abnormalities are found, medication should be discontinued. This medication is primarily metabolized in the liver, so dosage adjustments are necessary for patients with reduced liver function, and the risk of muscle-related side effects increases with dose escalation. This medication has many drug interactions, especially with cyclosporine, fibrates, niacin, and erythromycin, which can increase the risk of muscle damage and renal function deterioration; thus, caution should be exercised when co-administered. Elderly patients may have diminished physiological functions, increasing the likelihood of side effects, and dosage adjustments and monitoring are necessary. Pregnant or breastfeeding women should not take this medication as it may harm the fetus or infant, and women planning to become pregnant should also exercise caution. The safety of this medication in children has not been established, so it should not be used. Lastly, this medication should be stored out of reach of children and kept in its original container to prevent deterioration of quality or misuse.

Side effects

  • Abdominal pain
  • rash
  • malaise
  • paralysis
  • itching
  • muscle pain
  • weakness
  • elevated CPK levels
  • increased myoglobin in blood and urine
  • acute renal failure
Show 100 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • stiffness
  • drowsiness
  • insomnia
  • headache
  • heaviness in the head
  • dizziness
  • thirst
  • dyspepsia
  • abdominal bloating
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • gastric discomfort
  • diarrhea
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulins
  • positive Coombs test
  • anemia
  • frequent urination
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • elevated adrenocorticotropic hormone
  • elevated cortisol
  • decreased testosterone
  • muscle cramps
  • muscle pain
  • weakness
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • joint pain
  • swelling
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid levels
  • increased serum potassium and phosphorus
  • taste disturbance
  • malaise
  • positive antinuclear antibodies
  • sleep disorders
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • myasthenia gravis
  • ocular myasthenia gravis
  • facial swelling
  • arm swelling
  • hypersensitivity
  • headache
  • dizziness
  • skin tingling
  • insomnia
  • sleep disorders
  • loss of appetite
  • elevated blood pressure
  • chest discomfort
  • weakness
  • abdominal pain
  • dyspepsia
  • thirst
  • constipation
  • nausea
  • elevated γ-GT
  • increased LDH
  • elevated ALP
  • itching
  • urticaria
  • thrombocytopenia
  • increased serum creatinine
  • increased BUN
  • elevated blood pressure
  • skin tingling
  • chest discomfort

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that protects it from light. It is recommended to keep it at room temperature between 1 to 30 degrees Celsius, which helps maintain its efficacy and safety.

Appearance and packaging

Appearance

White, round film-coated tablets with a line.

Package unit

For domestic use) 100 tablets (10 tablets/PTP × 10), 300 tablets/bottle, for export) 30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.